These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23910729)

  • 1. The critical role of interleukin-23 in spondyloarthropathy.
    Sherlock JP; Buckley CD; Cua DJ
    Mol Immunol; 2014 Jan; 57(1):38-43. PubMed ID: 23910729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory pathways in spondyloarthritis.
    Hreggvidsdottir HS; Noordenbos T; Baeten DL
    Mol Immunol; 2014 Jan; 57(1):28-37. PubMed ID: 23969080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of ankylosing spondylitis.
    Robinson PC; Brown MA
    Mol Immunol; 2014 Jan; 57(1):2-11. PubMed ID: 23916070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates.
    Babaie F; Hasankhani M; Mohammadi H; Safarzadeh E; Rezaiemanesh A; Salimi R; Baradaran B; Babaloo Z
    Immunol Lett; 2018 Apr; 196():52-62. PubMed ID: 29409751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.
    Jethwa H; Bowness P
    Clin Exp Immunol; 2016 Jan; 183(1):30-6. PubMed ID: 26080615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade.
    Khan MA
    Rheumatology (Oxford); 2011 Apr; 50(4):637-9. PubMed ID: 21421688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some aspects of pathogenesis of ankylosing spondylitis].
    Erdes Sh
    Ter Arkh; 2011; 83(5):51-6. PubMed ID: 21780658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in our understanding of the pathogenesis of ankylosing spondylitis.
    Simone D; Al Mossawi MH; Bowness P
    Rheumatology (Oxford); 2018 Aug; 57(suppl_6):vi4-vi9. PubMed ID: 30445483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Explanatory models for HLA-b27 association of reactive arthritis as a paradigm for spondyloarthropathy].
    Braun J; Sieper J
    Med Klin (Munich); 1996 Sep; 91(9):574-9. PubMed ID: 8984316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advance of research on HLA-B27 and the immunological mechanism of ankylosing spondylitis].
    Li MY; Yao ZQ; Liu XY
    Sheng Li Ke Xue Jin Zhan; 2011 Feb; 42(1):16-20. PubMed ID: 21595182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and dynamic features of HLA-B27 subtypes.
    Uchanska-Ziegler B; Ziegler A; Schmieder P
    Curr Opin Rheumatol; 2013 Jul; 25(4):411-8. PubMed ID: 23673483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of ankylosing spondylitis--insights into pathogenesis.
    Brown MA; Kenna T; Wordsworth BP
    Nat Rev Rheumatol; 2016 Feb; 12(2):81-91. PubMed ID: 26439405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetical factors--other than HLA-B27--in "HLA-B27-associated diseases".
    Derhaag PJ
    Scand J Rheumatol Suppl; 1990; 87():122-6; discussion 126. PubMed ID: 2259881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and genomics of ankylosing spondylitis.
    Thomas GP; Brown MA
    Immunol Rev; 2010 Jan; 233(1):162-80. PubMed ID: 20192999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
    Sorrentino R; Böckmann RA; Fiorillo MT
    Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis.
    Mahmoudi M; Amirzargar AA; Jamshidi AR; Farhadi E; Noori S; Avraee M; Nazari B; Nicknam MH
    Eur Cytokine Netw; 2011 Dec; 22(4):175-80. PubMed ID: 22285486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic basis of the seronegative spondyloarthropathies.
    Ivanyi P
    Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis.
    Collado-Escobar MD; Nieto A; Matarán L; Raya E; Martín J
    J Rheumatol; 2000 Jun; 27(6):1461-3. PubMed ID: 10852271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
    Poddubnyy DA; Märker-Hermann E; Kaluza-Schilling W; Zeidler H; Braun J; Listing J; Sieper J; Rudwaleit M
    J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA-B27 polymorphism and spondyloarthropathies].
    Peixoto MJ; Gonzales T; Spinola H; Couto AR; Mora MG; Brehm A; Santos MR; Garrett F; Armas JB
    Acta Med Port; 2005; 18(4):283-93. PubMed ID: 16584661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.